The makers of a vaginal mesh implant have reached a settlement with a woman whose lawsuit was set for a state court trial in Atlantic City later this month. C.R. Bard's transvaginal mesh lawsuit settlement will reportedly provide compensation of an undisclosed amount to a... Read More

In Actos lawsuit news, Takeda Pharmaceuticals continues to defend claims that it failed to warn consumers that its flagship type 2 diabetes medication causes a disproportionately high risk for developing bladder cancer. A bundled complaint filed by fourteen plaintiffs recently joined the Actos products liability... Read More

A study published this month by Duke University raises new concerns about Medtronic's Infuse bone graft product. Published in the medical journal Neurosurgery, the study examines the potential link between the use of a bioengineered protein called BMP, which is contained in the Infuse bone graft, and... Read More

There are currently more than 430 similar lawsuits consolidated in a Zoloft MDL. As part of the early discovery process, a small number of cases will be chosen as the first trials to be heard in court, which could set a precedent for those to... Read More

Alleged Da Vinci robotic surgery complications have resulted in a growing number of injury reports and lawsuits nationwide. Now, a new study finds that problems with the revolutionary da Vinci robotic system may be underreported, asking the question: Despite numerous success stories and glowing reports from doctors,... Read More

As part of the global DePuy ASR hip recall, Johnson & Johnson pulled 93,000 of its faulty metal-on-metal implants off the market in 2010, including at least 37,000 in the United States. Now, legal insiders tell Bloomberg that J&J is considering paying more than $3... Read More

An Oregon district judge ruled that the bulk of the claims in an Infuse bone grafting device lawsuit will survive preemption motions filed by Medtronic, in regards to the manufacturer’s duties under federal law. The suit in question was filed by Richard D. Alton, who... Read More

Johnson & Johnson announced another recall last week, this time for its antipsychotic Risperdal Consta, due to concerns that the drug may not be sterile.  The Risperdal recall comes on the heels of dozens of recalls in recent years, costing the Brunswick, N.J.-based company hundreds... Read More